Shares of Bachem Holding AG (OTCMKTS:BCHMF – Get Free Report) were down 4.3% during mid-day trading on Thursday . The company traded as low as $87.34 and last traded at $87.34. Approximately 359 shares changed hands during mid-day trading, a decline of 45% from the average daily volume of 656 shares. The stock had previously closed at $91.23.
Bachem Price Performance
The business’s 50-day simple moving average is $88.27 and its 200-day simple moving average is $76.95.
Bachem Company Profile
Bachem Holding AG is a Switzerland‐based specialty biochemical company focused on the development, manufacturing and commercialization of peptides and oligonucleotides. Serving pharmaceutical and biotechnology clients as well as academic research institutions, the company offers a broad spectrum of products ranging from custom peptide synthesis for research applications to clinical and commercial‐grade active pharmaceutical ingredients (APIs). Bachem’s expertise extends to process development, scale‐up and GMP‐compliant production, supporting projects in therapeutic areas such as oncology, metabolic disorders and infectious diseases.
Founded in 1971 and headquartered in Bubendorf, Switzerland, Bachem has grown through strategic investments in production capacity and the acquisition of complementary peptide and oligonucleotide technologies.
Further Reading
- Five stocks we like better than Bachem
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Bachem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bachem and related companies with MarketBeat.com's FREE daily email newsletter.
